Topics
CNS Tumors | Treatment | Side effects | Epilepsy
Home > Publications > Topics > CNS Tumors > Treatment > Side effects > Epilepsy
Stefan
H, Bösebeck F, Rössler K.
Brain
tumor-associated epilepsies in adulthood: Current state of
diagnostic and individual treatment options.
Seizure.
2024 Jun 8:S1059-1311(24)00161-4. doi:
10.1016/j.seizure.2024.06.004. PMID:
38910076. Review˰
ˍ
Yamada N, Kuki I, Fukuoka M, Nukui M, Inoue T, Umaba R, Kunihiro
N, Yamasaki K, Uda T, Fujisaki H, Okazaki S.
Characteristics
of malignant brain tumor-associated epileptic spasms.
Epileptic
Disord. 2024 Jun 18. doi:
10.1002/epd2.20240. PMID:
38888438. Observational
study˰ ˍ
Yamaguchi J, Ohka F, Motomura K, Ishizaki T, Nakahara N, Fujitani
S, Nagatani T, Ohno M, Ando M, Kuwatsuka Y, Nishida K, Saito R.
A
multi-center, open-label, randomized clinical trial evaluating the
preventive effect of perampanel on craniotomy-induced
epileptogenesis in seizure-naive patients
with supratentorial brain tumors: study protocol for a GRAMPAS
trial.
Trials.
2024 Dec 24;25(1):849. doi:
10.1186/s13063-024-08693-7. PMID:
39716271. Interventional study protocol. ˍ
Zhang Y, Li H, Zhang B, Zhang J, Li C.
Efficacy
and safety of levetiracetam in preventing postoperative seizures
in adult patients with brain tumors: a meta-analysis.
Front
Neurol. 2025 Mar 7;16:1543905. doi:
10.3389/fneur.2025.1543905. PMID:
40125402. Meta-analysis. ˍ
Dantio CD, Fasoranti DO, Teng C, Li X.
Seizures
in brain tumors: pathogenesis, risk factors and management
(Review).
Int
J Mol Med. 2025 Mar 21;55(5):82. doi:
10.3892/ijmm.2025.5523. PMID:
40116082. Review. ˍ